Albemarle Corporation (NYSE:ALB – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Monday. The company traded as low as $89.17 and last traded at $90.2320, with a volume of 205,734 shares trading hands. The stock had previously closed at $93.53.
Analyst Ratings Changes
Several research firms recently issued reports on ALB. Argus cut their target price on Albemarle from $230.00 to $135.00 and set a “buy” rating on the stock in a research report on Wednesday, October 7th. Deutsche Bank lowered their price target on Albemarle from $155.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, November 9th. Rothschild & Co Redburn dropped their price target on Albemarle from $100.00 to $86.00 in a research note on Wednesday, November 11th. Barclays reduced their price objective on Albemarle from $109.00 to $95.00 and set an “equal weight” rating for the company in a research note on Friday, November 6th. Finally, Mizuho upgraded Albemarle from a “neutral” rating to an “outperform” rating and set a $130.00 target price on the stock in a research report on Wednesday, October 14th. Fifteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $152.63.
View Our Latest Report on Albemarle
Albemarle Stock Performance
The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 2.34. The firm’s 50 day simple moving average is $103.61 and its 200-day simple moving average is $145.56. The company has a market cap of $10.58 billion, a price-to-earnings ratio of 21.65, a PEG ratio of 0.59 and a beta of 1.34.
Albemarle (NYSE:ALB – Get Free Report) last issued its earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. The business had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.19) earnings per share. On average, sell-side analysts predict that Albemarle Corporation will post 10.64 EPS for the current year.
Albemarle Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be issued a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 dividend on an annualized basis and a yield of 1.8%. Albemarle’s dividend payout ratio is presently 39.61%.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the business. Entropy Technologies LP boosted its holdings in shares of Albemarle by 23.8% during the 3rd quarter. Entropy Technologies LP now owns 10,424 shares of the specialty chemicals company’s stock worth $1,103,000 after purchasing an additional 2,002 shares during the last quarter. FORA Capital LLC acquired a new stake in shares of Albemarle in the third quarter valued at approximately $2,237,000. EP Wealth Advisors LLC increased its holdings in shares of Albemarle by 7.6% in the third quarter. EP Wealth Advisors LLC now owns 11,857 shares of the specialty chemicals company’s stock valued at $1,254,000 after purchasing an additional 842 shares during the last quarter. Pathstone Holdings LLC increased its holdings in shares of Albemarle by 1.6% in the third quarter. Pathstone Holdings LLC now owns 16,482 shares of the specialty chemicals company’s stock valued at $1,745,000 after purchasing an additional 257 shares during the last quarter. Finally, Medallion Wealth Advisors LLC purchased a new position in Albemarle during the third quarter worth approximately $32,000. 92.87% of the stock is owned by hedge funds and other institutional investors.
Albemarle Company Profile
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
Featured Stories
- Five stocks we like better than Albemarle
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
